Acrivon Therapeutics, Inc.
ACRV
$1.33
$0.032.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.16% | -16.63% | -4.25% | 3.83% | 64.16% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -41.55% | -21.27% | 40.37% | -15.93% | -16.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.53% | -16.68% | -3.89% | 3.63% | 62.61% |
|
|
|||||
| Total Current Assets | -8.53% | -16.68% | -3.89% | 3.63% | 62.61% |
| Net Property, Plant & Equipment | 1.78% | -0.54% | -5.22% | 13.76% | -2.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.16% | 0.00% | 0.11% | 107.31% | 16.21% |
| Total Assets | -10.07% | -10.30% | -8.43% | -6.90% | 91.32% |
|
|
|||||
| Total Accounts Payable | -68.49% | 386.94% | -49.67% | 19.43% | -38.67% |
| Total Accrued Expenses | 25.61% | -45.43% | 26.03% | 39.45% | 48.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.89% | 4.54% | 1.63% | 6.34% | 3.60% |
| Total Finance Division Other Current Liabilities | 60.97% | -- | -- | -80.92% | 96.53% |
| Total Other Current Liabilities | 60.97% | -- | -- | -80.92% | 96.53% |
| Total Current Liabilities | -0.88% | -21.29% | 16.16% | 31.33% | 24.81% |
|
|
|||||
| Total Current Liabilities | -0.88% | -21.29% | 16.16% | 31.33% | 24.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.20% | -6.92% | -12.95% | -8.33% | -7.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.59% | -19.41% | 11.30% | 22.48% | 15.83% |
|
|
|||||
| Common Stock & APIC | 1.02% | 0.92% | 0.83% | 0.67% | 52.63% |
| Retained Earnings | -9.70% | -9.99% | -13.11% | -14.79% | -14.14% |
| Treasury Stock & Other | -62.54% | -36.69% | -42.84% | 4,215.79% | 72.86% |
| Total Common Equity | -10.82% | -9.27% | -10.21% | -8.87% | 100.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.82% | -9.27% | -10.21% | -8.87% | 100.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.82% | -9.27% | -10.21% | -8.87% | 100.09% |
|
|
|||||